A detailed history of Insight Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Insight Advisors, LLC holds 5,078 shares of NVO stock, worth $546,545. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,078
Previous 5,109 0.61%
Holding current value
$546,545
Previous $729,000 17.15%
% of portfolio
0.16%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$119.07 - $145.42 $3,691 - $4,508
-31 Reduced 0.61%
5,078 $604,000
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $108,966 - $130,456
888 Added 21.04%
5,109 $729,000
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $107,215 - $142,716
1,050 Added 33.11%
4,221 $541,000
Q4 2023

Jan 23, 2024

BUY
$87.78 - $105.45 $278,350 - $334,381
3,171 New
3,171 $328,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Insight Advisors, LLC Portfolio

Follow Insight Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Advisors, LLC with notifications on news.